Your browser doesn't support javascript.
COVID-19, community trials, and inclusion.
Gill, Paramjit S; Poduval, Shoba; Thakur, Jarnail S; Iqbal, Romaina.
  • Gill PS; Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK. Electronic address: p.gill.1@warwick.ac.uk.
  • Poduval S; UCL eHealth Unit, Department of Primary Care and Population Health, University College London, London, UK.
  • Thakur JS; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Iqbal R; Department of Community Health Sciences, Aga Khan University. Karachi, Pakistan.
Lancet ; 397(10279): 1036-1037, 2021 03 20.
Article in English | MEDLINE | ID: covidwho-1142337
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azithromycin / COVID-19 Drug Treatment Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Azithromycin / COVID-19 Drug Treatment Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Year: 2021 Document Type: Article